Bill Texts: KS SB236 | 2023-2024 | Regular Session

Bill Title: Requiring drug manufacturers to provide pricing under the federal 340B drug pricing program to pharmacies that enter into contractual agreements with entities covered under the 340B program and prohibiting pharmacy benefits managers from denying patients the freedom to use the pharmacy and healthcare provider of such patient's choice.

Sponsorship: Committee Bill

Status: (Failed) 2024-04-30 - Senate Died in Committee [SB236 Detail]

Bill Drafts

RevisionDateFormatSourceView
Introduced2023-02-10PDFLinkView

Amendments

AmendmentDateDispositionFormatSourceView
No bill amendments currently on file for Kansas SB236

Supplemental Documents

TitleDescriptionDateFormatSourceView
Fiscal NoteFicsal Note: As introducedNot AvailPDFLinkView

feedback